Back
Novo Nordisk A/S Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
60
NVO
Novo Nordisk A/S
Last Price:
131.88
Seasonality Move:
4.24%
Buy
72
VRTX
Vertex Pharmaceuticals
Last Price:
445.29
Seasonality Move:
7.52%
Buy
60
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NVO] share price is $131.89. The Score for NVO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- NVO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $445.21. The Score for VRTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $131.89
The current trend is moderately bullish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $445.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.76 | Buy |
| Relative Strength Index (14 RSI): | 58.61 | Buy |
| Chaikin Money Flow: | 1764720 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.84 - 130.72) | Buy |
| Bollinger Bands (100): | (111.58 - 130.72) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.17 | Buy |
| Relative Strength Index (14 RSI): | 79.02 | Buy |
| Chaikin Money Flow: | 929485 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.09 | Buy |
| 20-day SMA: | 128.24 | Buy |
| 50-day SMA: | 128.16 | Buy |
| 200-day SMA: | 108.64 | Buy |
| 8-day EMA: | 131.23 | Buy |
| 20-day EMA: | 129.03 | Buy |
| 50-day EMA: | 126.45 | Buy |
| 200-day EMA: | 110.39 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 430.31 | Buy |
| 20-day SMA: | 412.4 | Buy |
| 50-day SMA: | 409.66 | Buy |
| 200-day SMA: | 388.13 | Buy |
| 8-day EMA: | 430.92 | Buy |
| 20-day EMA: | 418.59 | Buy |
| 50-day EMA: | 412.7 | Buy |
| 200-day EMA: | 390.21 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.78 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
Novo Nordisk A/S Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||